Antiproteinuric and renoprotective effects of ACE inhibitors and angiotensin II receptor blockers
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Antiproteinuric and Renoprotective Effects of ACE Inhibitors and Angiotensin II Receptor Blockers." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/455860/0/.
Antiproteinuric and renoprotective effects of ACE inhibitors and angiotensin II receptor blockers. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/455860/0/. Accessed May 2, 2024.
Antiproteinuric and renoprotective effects of ACE inhibitors and angiotensin II receptor blockers. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/455860/0/
Antiproteinuric and Renoprotective Effects of ACE Inhibitors and Angiotensin II Receptor Blockers [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 May 02]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/455860/0/.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Antiproteinuric and renoprotective effects of ACE inhibitors and angiotensin II receptor blockers
ID - 455860
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/455860/0/
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -